Understanding Practice Patterns and Low-density Lipoprotein Cholesterol Goal Attainment Implications of Switching Patients From Simvastatin in a Health Plan SettingByCaroline R. Harley, PhD,Sanjay K. Gandhi, PhD,Nze Anoka, MS, MBA,Michael F. Bullano, PharmD,James M. McKenney, PharmDDecember 1st 2007
Comparison of Low-density Lipoprotein Cholesterol Reduction After Switching Patients on Other Statins to Rosuvastatin or Simvastatin in a Real-world Clinical Practice SettingByKathleen M. Fox, PhD,Sanjay K. Gandhi, PhD,Robert L. Ohsfeldt, PhD,Michael H. Davidson, MD, FACC, FACPDecember 1st 2007
Overview of Prevention and Treatment of Atherosclerosis With Lipid-altering Therapy for Pharmacy DirectorsByMichael H. Davidson, MD, FACC, FACPDecember 1st 2007
